NCT03257085

Brief Summary

Pilot study to compare the impact of following a low-carbohydrate, high-fat diet versus following a high-carbohydrates, moderate-fat diet (UK dietary guidelines) on cardiometabolic risk markers and associated behaviours in a normal-weight and overweight adult population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 9, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 14, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 22, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2017

Completed
Last Updated

March 8, 2018

Status Verified

March 1, 2018

Enrollment Period

9 months

First QC Date

August 14, 2017

Last Update Submit

March 7, 2018

Conditions

Outcome Measures

Primary Outcomes (9)

  • Serum lipid profile

    Total cholesterol, HDL-C, LDL-C, non-HDL cholesterol, small-dense LDL-C and triglycerides measured in mmol/L

    8 weeks

  • Blood glucose

    Measured in mmol/L

    8 weeks

  • Systolic and diastolic blood pressure

    Measured in mmHg

    8 weeks

  • Inflammatory markers, such as CRP

    Measured in mg/L

    8 weeks

  • Adiponectin

    Measured in μg/mL

    8 weeks

  • Fibroblast growth factor 21 (FGF21).

    Measured in pg/mL

    8 weeks

  • Tumor necrosis factor alpha and Interleukin 6

    Measured in μg/mL

    8 weeks

  • Body composition - Bioelectrical impedance

    Lean mass, fat mass and adipose tissue location and distribution

    8 weeks

  • Body composition - Anthropometrics

    Waist, hip, neck, thigh and calf circumference measured in cm

    8 weeks

Secondary Outcomes (11)

  • Clinical traditional and emerging markers of dietary intake

    8 weeks

  • Food cravings

    8 weeks

  • Satiety

    8 weeks

  • Cognition

    8 weeks

  • Impact on physical activity patterns

    8 weeks

  • +6 more secondary outcomes

Study Arms (2)

Low-carbohydrate, high-fat

EXPERIMENTAL

Participants adhering to low-carbohydrate, high-fat diet for 8 weeks.

Other: Low-carbohydrate, high-fat

High-carbohydrate, moderate fat

EXPERIMENTAL

Participants following high-carbohydrate, moderate-fat diet for 8 weeks.

Other: High-carbohydrate, moderate-fat

Interventions

Participants following low-carbohydrate, high-fat diet for 8 weeks.

Also known as: CALIBER LCHF
Low-carbohydrate, high-fat

Participants following high-carbohydrate, moderate-fat diet (UK dietary guidelines) for 8 weeks.

Also known as: CALIBER HCMF
High-carbohydrate, moderate fat

Eligibility Criteria

Age19 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI 18.5 - 29.9kg/m2
  • Aged 19 - 64
  • White-Caucasian
  • Score of ≥4 from a combination of risk markers, including
  • Fasting glucose concentration \>5.5mmol/L = 3 points
  • Waist \>102cm or 40 inches = 2 points (males)
  • Waist \>94 cm or 37 inches = 1 point (males)
  • Waist \>88cm or 34inches = 2 points (females)
  • Waist \>80 cm or 31 inches = 1 point (females)
  • Systolic blood pressure\>130mmHg = 1 point
  • Diastolic BP \>85mmHg = 1 point
  • HDL cholesterol concentration \<1.0mmol/L = 2 points
  • Serum triglyceride concentration \>1.3mmol/L = 1 point.

You may not qualify if:

  • Smoker
  • Vegetarian or vegan
  • Suffering from food allergies or intolerances
  • Drinking alcohol above recommended UK government guidelines
  • Previous diagnosis of CM disease
  • Taking lipid-lowering medication
  • Taking blood pressure-lowering medication
  • Taking blood glucose-lowering medication
  • Taking dietary supplements
  • Suffering from an eating disorder
  • Current or previous renal impairment
  • BMI 18.5 - 29.9kg/m2
  • Aged 19 - 64
  • White-Caucasian
  • Smoker
  • +10 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Liverpool John Moores University

Liverpool, Merseyside, L17 6BD, United Kingdom

Location

Related Links

Study Officials

  • Ian G Davies, PhD

    Liverpool John Moores University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the nature of the low-carbohydrate, high-fat and high-carbohydrate, moderate-fat diets masking is not feasible.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomised pilot study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Researcher and Registered Associate Nutritionist

Study Record Dates

First Submitted

August 14, 2017

First Posted

August 22, 2017

Study Start

March 9, 2017

Primary Completion

December 8, 2017

Study Completion

December 8, 2017

Last Updated

March 8, 2018

Record last verified: 2018-03

Locations